xylazine has been researched along with Lung Neoplasms in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MZ | 1 |
| Crowley, PD | 1 |
| Foley, AG | 1 |
| Xue, C | 1 |
| Connolly, C | 1 |
| Gallagher, HC | 1 |
| Buggy, DJ | 1 |
1 other study available for xylazine and Lung Neoplasms
| Article | Year |
|---|---|
Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model.
Topics: Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Local; A | 2018 |